Home » Topics » Disease categories and therapies » Infection

Infection
RSS

New treatment options improve outlook for patients with viral skin infections

Dec. 3, 1996

Lidak reacquires certain rights to Lidakol from BMS

Dec. 2, 1996

Ivermectin approved for use in humans

Dec. 2, 1996

Merck & Co. describes lipid A biosynthesis inhibitor with antibacterial activity

Dec. 2, 1996

Frog peptides with antimicrobial activity available for licensing

Dec. 2, 1996

Antimicrobial peptide combinations available for licensing

Dec. 2, 1996

Takeda describes antiprotozoal agents

Nov. 29, 1996

Antimicrobial ranalexin peptides available for licensing

Nov. 28, 1996

New antibacterial agents under study at Bayer

Nov. 28, 1996

FDA approves Amphotec

Nov. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...